Dr. Walter G. Copan – Congressional Testimony: The State of U.S. Science and Technology: Ensuring U.S. Global Leadership

On February 5th, 2025, Dr. Walter G. Copan testified before the House Committee on Science, Space, and Technology on the State of U.S. Science and Technology: Ensuring U.S. Global Leadership.

Copan, Vice President for Research and Technology Transfer at the Colorado School of Mines, former Director of the National Institute of Standards and Technology (NIST), and CSIS Senior Adviser, emphasized the crucial role of investment in public-sector R&D, as well as STEM education and workforce training.

“Two decades ago, the United States was the undisputed global leader in science and technology, and in driving innovation for economic value creation. Today, however, by many internationally recognized measures, America’s global leadership position in the majority of the critical technology fields has been overtaken by China.”

“We are in a period where crisis presents America with great opportunity. The U.S. must take a new strategic approach to the future of research and S&T advancement that engages across government agencies. We must leverage collaboration and investments with the private sector, bolster education at all levels, and engage with our national R&D, intellectual property, standards and innovation enterprise. We have the chance to drive great synergies in federal R&D investment, through a national S&T and innovation strategy.”

Watch the full hearing here, and read Dr. Copan’s opening remarks here.

The United States Needs a National Standards Strategy

By Richard Taffet and Chris Borges Competition among nations for technological and economic leadership is intense, especially between the United States and the People’s Republic of China (PRC). The PRC has followed a decades-long, targeted strategy focused on leadership in critical and emerging technologies (CETs), and, according to some, it has
Read More

How Most-Favored Nation Policy Could Undermine U.S. Leadership

By Dr. Anne Pritchett The United States is the global leader in biopharmaceutical innovation. This leadership is built on the pillars of strong intellectual property protection, substantial investment in research and development (R&D), and a robust innovation ecosystem. These factors, combined with a market-based system that supports competitive drug pricing, encourage innovation and
Read More

U.S. Patenting Abroad — A Quiet Trade Advantage

By Chris Borges   Although patents are territorial, meaning they are limited to the jurisdiction in which they are granted, the networks spanning innovation and commerce are global. U.S. inventors routinely seek patent protection in markets abroad to safeguard their innovations, facilitate exports, and access new customers. By requiring member states
Read More